Hyaluronic Acid and Vaginal Distress

University of Messina70 enrolled

Overview

The purpose of this trial is to study the effects of the oral supplementation hyaluronic acid in menopause women with vaginal distress for treatment vaginal distress.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Vaginal Disease

Interventions

hyaluronic acid pillOTHER

pill, 220 mg, once a day, three months

Eligibility

Sex: FEMALEMin age: 45 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * menopause * vaginal distress * no other therapy Exclusion Criteria: * vaginal infection * Sjogren Syndrome

Locations (1)

Menopause centre of the G. Martino University Policlinic

Messina, Sicily, Italy

Outcomes

Primary Outcomes

effects of the oral somministration hyaluronic acid in menopause women with vaginal distress

Time frame: three months

Central Contacts

Tindara LT La Galia, PhD student

CONTACT

+393470635155 giusy.lagalia@yahoo.it

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.